A Multicenter Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate- Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight and Obese Adults
Condition:   Chronic Weight ManagementInterventions:   Drug: lorcaserin;   Drug: phentermine-HCl;   Drug: phentermine placebo BIDSponsor:   Eisai Inc.Active, not recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2013 Category: Research Source Type: clinical trials

A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate-Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight and Obese Adults
Condition:   Chronic Weight ManagementInterventions:   Drug: lorcaserin + phentermine placebo;   Drug: lorcaserin + phentermine-HCl + phentermine placebo;   Drug: lorcaserin + phentermine-HClSponsor:   Eisai Inc.Completed - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 12, 2013 Category: Research Source Type: clinical trials

A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate-Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight and Obese Adults
Condition:   Chronic Weight ManagementInterventions:   Drug: lorcaserin + phentermine placebo;   Drug: lorcaserin + phentermine-HCl + phentermine placebo;   Drug: lorcaserin + phentermine-HClSponsor:   Eisai Inc.Completed - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 12, 2013 Category: Research Source Type: clinical trials

Peripheral Pharmacodynamics of Phentermine_Topiramate in Obese Patients
Condition:   ObesityInterventions:   Drug: Phentermine-Topiramate;   Drug: Matched-PlaceboSponsors:   Mayo Clinic;   Mayo ClinicNot yet recruiting - verified April 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2013 Category: Research Source Type: clinical trials

Peripheral Pharmacodynamics of Phentermine_Topiramate in Obese Patients
Condition:   ObesityInterventions:   Drug: Phentermine-Topiramate;   Drug: Matched-PlaceboSponsor:   Mayo ClinicRecruiting - verified January 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2013 Category: Research Source Type: clinical trials